Evidence map›Paper›PMID 31323273›Full record

ArticleLife sciences2019

The effects of Tel2 on cardiomyocyte survival.

Naaiko Yorichika, Yuichi Baba, Briana K Shimada, Manoj Thakore, Sharon M Wong, Motoi Kobayashi, Jason K Higa, Takashi Matsui

Open access · greenAbstract read
In one paragraph

Article in Life sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Naaiko YorichikaDepartment of Anatomy, Biochemistry & Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, HI, United States of America.
Yuichi BabaDepartment of Anatomy, Biochemistry & Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, HI, United States of America; Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Kochi, Japan.
Briana K ShimadaDepartment of Anatomy, Biochemistry & Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, HI, United States of America.
Manoj ThakoreDepartment of Anatomy, Biochemistry & Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, HI, United States of America.
Sharon M WongDepartment of Anatomy, Biochemistry & Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, HI, United States of America.
Motoi KobayashiDepartment of Anatomy, Biochemistry & Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, HI, United States of America.
Jason K HigaDepartment of Anatomy, Biochemistry & Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, HI, United States of America.
Takashi MatsuiDepartment of Anatomy, Biochemistry & Physiology, John A. Burns School of Medicine, University of Hawai'i at Manoa, HI, United States of America. Electronic address: tmatsui@hawaii.edu.
University of Hawaiʻi at Mānoa · USKōchi University · JP

Funding

TRPA1 Physiology in Diabetes, Metabolic Syndrome, and MetabolismP20GM113134 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI Kathryn Jaques Schunke · 2017 to 2026
$21.5M
Role of mTOR in the diabetic heartR01HL098423 · NHLBI · UNIVERSITY OF HAWAII AT MANOA · PI MATSUI, TAKASHI · 2010 to 2013
$1.5M
NHLBI NIH HHS R01 HL098423NIGMS NIH HHS P20 GM113134
6 · The paper itself

Abstract

aimsOverexpression of the mechanistic target of rapamycin (mTOR), a member of the PIKK (phosphoinositide kinase-related kinase) family, protects cardiomyocytes from cell death induced by pathological stimuli such as ischemia. We previously reported that posttranslational modification of mTOR plays an important role in regulating cardiac mTOR expression. The aim of this study was to see if Tel2 (telomere maintenance 2), a protein that regulates the abundance of PIKKs, confers similar cardioprotective effects as mTOR. Tel2 is not well-characterized in cardiomyocytes, therefore we examined the effects of Tel2 on cardiomyocyte viability under ischemic stress conditions. MATERIALS AND

methodsWe overexpressed Tel2 or silenced Tel2 with siRNA in the HL-1 cardiomyocyte cell line to survey the effects of Tel2 overexpression and downregulation on cell survival during hypoxia. Adult mouse cardiomyocytes transfected with Tel2 adenoviruses were used to test whether Tel2 sufficiently prevented cardiomyocyte cell death against hydrogen peroxide (H KEY

findingsOverexpressing Tel2 increased mTOR expression with a concomitant increase in mTOR Complex 1 (mTORC1) and mTORC2 activity in HL-1 cells. Tel2 deletion decreased mTOR expression, and mTORC1 and mTORC2 activity accordingly. In both HL-1 cells and adult mouse cardiomyocytes, Tel2 overexpression protected cardiomyocytes under ischemic stress. These effects were mTOR-dependent, as mTOR inhibitors blunted the effects of Tel2. While gene silencing of Tel2 did not affect cell survival under normoxia, Tel2 silencing made cardiomyocytes more vulnerable to cell death under hypoxia. SIGNIFICANCE: Upregulating Tel2 expression increases mTOR-mediated cardiomyocyte survival and targeting Tel2 could be another therapeutic strategy against ischemic heart disease.

Indexed as

AdenoviridaeAnimalsCell DeathCell LineCell SurvivalGene SilencingHydrogen PeroxideMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2MiceMyocytes, CardiacSignal TransductionTelomere-Binding ProteinsTransfectionHydrogen PeroxideMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Tel2 protein, mouseTelomere-Binding ProteinsAdenoviral gene transferApoptosisCardiomyocyteCell deathmTOR

Identifiers

PMID31323273
PMCPMC6698408
OpenAlexW2956960274

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.